XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:      
Net Income (Loss) $ 1,720,716 $ (142,077) $ (498,643)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Continuing Operating Activities:      
Depreciation, Depletion and Amortization 433,586 461,215 515,118
Amortization of Deferred Financing Costs 9,275 8,456 27,052
Stock-Based Compensation 20,235 16,375 16,560
Gain on Asset Sales and Abandonments, net (132,372) (8,984) (42,210)
Loss on Debt Extinguishment 0 22,953 33,737
(Gain) Loss on Commodity Derivative Instruments (1,928,652) 2,663,775 1,632,733
Loss (Gain) on Other Derivative Instruments 3,463 (10,348) (8,485)
Net Cash Received (Paid) in Settlement of Commodity Derivative Instruments 79,523 (1,735,115) (539,016)
Deferred Income Taxes 497,432 (76,058) (137,887)
Other (1,967) 5,588 (1,280)
Changes in Operating Assets:      
Accounts and Notes Receivable 222,751 (20,338) (184,461)
Supplies Inventories 7,310 (21,008) 1,487
Recoverable Income Taxes 0 72 17
Prepaid Expenses 1,227 (252) (3,204)
Changes in Other Assets 75 21,499 (23,838)
Changes in Operating Liabilities:      
Accounts Payable (55,309) 53,772 3,006
Accrued Interest 7,483 710 9,486
Other Operating Liabilities (67,140) (267) 107,498
Changes in Other Liabilities (3,048) (4,954) 18,687
Net Cash Provided by Operating Activities 814,588 1,235,014 926,357
Cash Flows from Investing Activities:      
Capital Expenditures (679,404) (565,754) (465,861)
Proceeds from Asset Sales 170,027 37,460 45,251
Net Cash Used in Investing Activities (509,377) (528,294) (420,610)
Cash Flows from Financing Activities:      
Payments on Long-Term Notes 0 (385,719) (421,467)
Payments on Other Debt (1,627) (665) (2,785)
Proceeds from Issuance of Common Stock 1,760 1,197 5,087
Shares Withheld for Taxes (9,500) (5,852) (4,553)
Purchases of Common Stock (319,866) (565,125) (245,243)
Debt Issuance and Financing Fees (356) (3,250) (14,476)
Net Cash Used in Financing Activities (326,089) (688,964) (523,781)
Net (Decrease) Increase in Cash and Cash Equivalents (20,878) 17,756 (18,034)
Cash and Cash Equivalents at Beginning of Period 21,321 3,565 21,599
Cash and Cash Equivalents at End of Period 443 21,321 3,565
CNX Senior Notes      
Cash Flows from Financing Activities:      
Proceeds from issuance of senior notes 0 493,750 0
CNXM Senior Notes      
Cash Flows from Financing Activities:      
Repayments of revolving credit facility borrowings 0 0 (160,544)
Proceeds from issuance of senior notes 0 0 395,000
CNXM Revolving Credit Facility      
Cash Flows from Financing Activities:      
Proceeds from revolving credit facility borrowings 333,575 343,900 391,500
Repayments of revolving credit facility borrowings (382,125) (375,200) (497,500)
CNX Revolving Credit Facility      
Cash Flows from Financing Activities:      
Proceeds from revolving credit facility borrowings 1,588,350 3,332,875 1,725,800
Repayments of revolving credit facility borrowings $ (1,536,300) $ (3,524,875) $ (1,694,600)